AI + Bioscience Anti-Inflammation & Anti-Bacterial Therapies

Bluestone Bio is headquartered in North Bethesda, Maryland, in close proximity to the National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA), and the U.S. Pharmacopeia. This strategic location provides access to a highly skilled pool of academic researchers and fosters collaborations with world-class scientific and regulatory institutions.

At Bluestone Bio, we believe modern bioscience, powered by artificial intelligence, can accelerate breakthroughs against two of the most urgent health challenges: chronic inflammation and bacterial resistance. Our mission is to transform cutting-edge research into safe, effective, and accessible solutions — from novel drugs to next-generation dietary supplements.

We deploy proprietary machine learning models trained on multi-omics data, scientific literature, and patient biology to identify new therapeutic targets and optimize compounds faster than traditional methods.

Our labs combine cell biology, chemical synthesis, structural biology, and microbiome analysis to validate AI predictions and ensure safety, potency, and specificity.

We design global development pathways — from investigational therapeutics to nutraceuticals — ensuring regulatory compliance and real-world readiness.